BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 33463407)

  • 1. Mining of Ebola virus genome for the construction of multi-epitope vaccine to combat its infection.
    Shankar U; Jain N; Mishra SK; Sk MF; Kar P; Kumar A
    J Biomol Struct Dyn; 2022 Jul; 40(11):4815-4831. PubMed ID: 33463407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational design of a potential multi-epitope subunit vaccine using immunoinformatics to fight Ebola virus.
    Kadam A; Sasidharan S; Saudagar P
    Infect Genet Evol; 2020 Nov; 85():104464. PubMed ID: 32681997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of multi-epitope based vaccine against
    Nayak SS; Sethi G; Ramadas K
    J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a multi-epitope vaccine against six Nocardia species based on reverse vaccinology combined with immunoinformatics.
    Zhu F; Tan C; Li C; Ma S; Wen H; Yang H; Rao M; Zhang P; Peng W; Cui Y; Chen J; Pan P
    Front Immunol; 2023; 14():1100188. PubMed ID: 36845087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach.
    Alizadeh M; Amini-Khoei H; Tahmasebian S; Ghatrehsamani M; Ghatreh Samani K; Edalatpanah Y; Rostampur S; Salehi M; Ghasemi-Dehnoo M; Azadegan-Dehkordi F; Sanami S; Bagheri N
    Sci Rep; 2022 May; 12(1):7757. PubMed ID: 35545650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome-wide screening for designing a multi-epitope vaccine against emerging pathogen
    Nain Z; Abdulla F; Rahman MM; Karim MM; Khan MSA; Sayed SB; Mahmud S; Rahman SMR; Sheam MM; Haque Z; Adhikari UK
    J Biomol Struct Dyn; 2020 Oct; 38(16):4850-4867. PubMed ID: 31709929
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploring staphylococcal superantigens to design a potential multi-epitope vaccine against
    Rahman S; Sarkar K; Das AK
    J Biomol Struct Dyn; 2023; 41(22):13098-13112. PubMed ID: 36729064
    [No Abstract]   [Full Text] [Related]  

  • 9. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
    Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
    Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome based mapping and reverse vaccinology techniques to contrive multi-epitope based subunit vaccine (MEBSV) against Streptococcus pyogenes.
    Aslam S; Ashfaq UA; Zia T; Aslam N; Alrumaihi F; Shahid F; Noor F; Qasim M
    Infect Genet Evol; 2022 Jun; 100():105259. PubMed ID: 35231667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing of cytotoxic T lymphocyte-based multi-epitope vaccine against SARS-CoV2: a reverse vaccinology approach.
    Vivekanandam R; Rajagopalan K; Jeevanandam M; Ganesan H; Jagannathan V; Selvan Christyraj JD; Kalimuthu K; Selvan Christyraj JRS; Mohan M
    J Biomol Struct Dyn; 2022; 40(24):13711-13726. PubMed ID: 34696708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring whole proteome to contrive multi-epitope-based vaccine for NeoCoV: An immunoinformtics and
    Aziz S; Waqas M; Halim SA; Ali A; Iqbal A; Iqbal M; Khan A; Al-Harrasi A
    Front Immunol; 2022; 13():956776. PubMed ID: 35990651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus.
    Ullah MA; Sarkar B; Islam SS
    Immunobiology; 2020 May; 225(3):151949. PubMed ID: 32444135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employing an immunoinformatics approach revealed potent multi-epitope based subunit vaccine for lymphocytic choriomeningitis virus.
    Waqas M; Aziz S; Bushra A; Halim SA; Ali A; Ullah S; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Feb; 16(2):214-232. PubMed ID: 36603375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
    Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
    Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach.
    Aziz S; Almajhdi FN; Waqas M; Ullah I; Salim MA; Khan NA; Ali A
    Front Immunol; 2022; 13():1004804. PubMed ID: 36311762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology.
    Joshi A; Akhtar N; Sharma NR; Kaushik V; Borkotoky S
    J Biomol Struct Dyn; 2023; 41(22):12464-12479. PubMed ID: 36935104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoinformatic based designing of potential immunogenic novel mRNA and peptide-based prophylactic vaccines against H5N1 and H7N9 avian influenza viruses.
    Ghafoor D; Zeb A; Ali SS; Ali M; Akbar F; Ud Din Z; Ur Rehman S; Suleman M; Khan W
    J Biomol Struct Dyn; 2024 Apr; 42(7):3641-3658. PubMed ID: 37222664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of B-cell and T-cell multi epitope-based vaccine against Zika virus, an
    Ganji M; Bakhshi S; Ahmadi K; Shoari A; Moeini S; Ghaemi A
    J Biomol Struct Dyn; 2024 Apr; 42(7):3426-3440. PubMed ID: 37190978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.
    Wang Y; Wu A; Xu Z; Zhang H; Li H; Fu S; Liu Y; Cui L; Miao Y; Wang Y; Zhumanov K; Xu Y; Sheng J; Yi J; Chen C
    Int Immunopharmacol; 2024 Jan; 127():111351. PubMed ID: 38113688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.